GB9817082D0 - Attenuated poliovirus vaccine - Google Patents
Attenuated poliovirus vaccineInfo
- Publication number
- GB9817082D0 GB9817082D0 GBGB9817082.2A GB9817082A GB9817082D0 GB 9817082 D0 GB9817082 D0 GB 9817082D0 GB 9817082 A GB9817082 A GB 9817082A GB 9817082 D0 GB9817082 D0 GB 9817082D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- poliovirus vaccine
- attenuated poliovirus
- attenuated
- vaccine
- poliovirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 229940124867 Poliovirus vaccine Drugs 0.000 title 1
- 230000002238 attenuated effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
- C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9817082.2A GB9817082D0 (en) | 1998-08-06 | 1998-08-06 | Attenuated poliovirus vaccine |
GB9917024A GB2344590B (en) | 1998-08-06 | 1999-07-20 | Attenuated poliovirus vaccine |
PCT/GB1999/002332 WO2000007622A1 (en) | 1998-08-06 | 1999-07-20 | Attenuated poliovirus vaccine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9817082.2A GB9817082D0 (en) | 1998-08-06 | 1998-08-06 | Attenuated poliovirus vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9817082D0 true GB9817082D0 (en) | 1998-10-07 |
Family
ID=10836776
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9817082.2A Ceased GB9817082D0 (en) | 1998-08-06 | 1998-08-06 | Attenuated poliovirus vaccine |
GB9917024A Expired - Fee Related GB2344590B (en) | 1998-08-06 | 1999-07-20 | Attenuated poliovirus vaccine |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9917024A Expired - Fee Related GB2344590B (en) | 1998-08-06 | 1999-07-20 | Attenuated poliovirus vaccine |
Country Status (2)
Country | Link |
---|---|
GB (2) | GB9817082D0 (en) |
WO (1) | WO2000007622A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0615933D0 (en) | 2006-08-10 | 2006-09-20 | Nat Inst Biological Standards & Control | Attenuated polioviruses |
BRPI0809600B1 (en) | 2007-03-30 | 2023-01-24 | The Research Foundation Of State University Of New York | ATENUE VIRUS USEFUL FOR VACCINES |
US8305914B2 (en) | 2007-04-30 | 2012-11-06 | Hewlett-Packard Development Company, L.P. | Method for signal adjustment through latency control |
GB201022077D0 (en) * | 2010-12-29 | 2011-02-02 | Health Prot Agency | Inactivated poliovaccine |
GB201700825D0 (en) * | 2017-01-17 | 2017-03-01 | Sec Dep For Health | Poliovaccine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8901093D0 (en) * | 1989-01-18 | 1989-03-15 | Almond Jeffrey W | Attenuated viruses |
GB9107563D0 (en) * | 1991-04-10 | 1991-05-29 | Macadam Andrew J | Thermostable viruses |
-
1998
- 1998-08-06 GB GBGB9817082.2A patent/GB9817082D0/en not_active Ceased
-
1999
- 1999-07-20 WO PCT/GB1999/002332 patent/WO2000007622A1/en active Application Filing
- 1999-07-20 GB GB9917024A patent/GB2344590B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB2344590A (en) | 2000-06-14 |
GB2344590B (en) | 2000-11-08 |
WO2000007622A1 (en) | 2000-02-17 |
GB9917024D0 (en) | 1999-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2337755B (en) | Virus vaccine | |
GB9711964D0 (en) | Live attenuated vaccines | |
IL140094A0 (en) | Vaccine | |
GB9806456D0 (en) | Vaccine composition | |
HUP0105392A3 (en) | Enhanced vaccines | |
IL137449A0 (en) | Live vaccine against brucellosis | |
GB9822714D0 (en) | Vaccines | |
IL139467A0 (en) | Vaccine | |
GB2344590B (en) | Attenuated poliovirus vaccine | |
GB9801870D0 (en) | Vaccine composition | |
HUP0101652A3 (en) | Hepatitis vaccine | |
GB9823835D0 (en) | Component for vaccine | |
GB9807805D0 (en) | Vaccine | |
GB9820956D0 (en) | Vaccine | |
GB9821821D0 (en) | Schistomiasis vaccine | |
GB9805962D0 (en) | Vaccine | |
GB9822712D0 (en) | Vaccine | |
GB9805961D0 (en) | Vaccine | |
GB9802543D0 (en) | Vaccine | |
GB9828035D0 (en) | Vaccine | |
GB9812773D0 (en) | Vaccine | |
GB9811954D0 (en) | Vaccine | |
GB9805960D0 (en) | Vaccine | |
GB9802544D0 (en) | Vaccine | |
GB9807933D0 (en) | Vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |